Author: Owa, Adewale Bayode; Owa, Olufunke Tolulope
Title: Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial? Cord-id: oxgdsuuo Document date: 2020_5_25
ID: oxgdsuuo
Snippet: Abstract Covid-19 infection caused by the novel coronavirus SARS-COV-2 continues to be a major global health challenge. Till date, no drug has been approved for the treatment of this infection. A number of medications have been proposed and there are ongoing clinical trials around the world to find a suitable treatment. A recent randomised control trial compared lopinavir/ritonavir with standard care among 199 patients with severe Covid-19 infection and concluded that there was no significant re
Document: Abstract Covid-19 infection caused by the novel coronavirus SARS-COV-2 continues to be a major global health challenge. Till date, no drug has been approved for the treatment of this infection. A number of medications have been proposed and there are ongoing clinical trials around the world to find a suitable treatment. A recent randomised control trial compared lopinavir/ritonavir with standard care among 199 patients with severe Covid-19 infection and concluded that there was no significant reduction in mortality rate with lopinavir/ritonavir. However, there are a few important lessons which may be learnt from the study apart from the statistical reduction in mortality rate. There was a numerical reduction in mortality rate, less intensive care unit stay and less complications in the lopinavir-ritonavir group. This article points out some of those important lessons with some suggestions for future clinical trials.
Search related documents:
Co phrase search for related documents- acute kidney injury and lopinavir patient: 1
- acute kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute kidney injury and lopinavir ritonavir treatment: 1, 2, 3, 4, 5
- acute kidney injury and low infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute kidney injury and low mortality rate: 1
- acute kidney injury and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- lopinavir infection ritonavir and low infection: 1
- lopinavir ritonavir and low infection: 1, 2, 3
- lopinavir ritonavir and low mortality rate: 1, 2
- lopinavir ritonavir and lung infection: 1, 2, 3, 4, 5, 6, 7, 8
- lopinavir ritonavir group and lung infection: 1
- lopinavir ritonavir treatment and low infection: 1, 2
- lopinavir ritonavir treatment and low mortality rate: 1
- lopinavir ritonavir treatment and lung infection: 1, 2
- low infection and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
Co phrase search for related documents, hyperlinks ordered by date